Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 35,500 | |||
5 mg | 在庫あり | ¥ 91,500 | |||
10 mg | 在庫あり | ¥ 144,500 | |||
25 mg | 在庫あり | ¥ 224,500 | |||
50 mg | 在庫あり | ¥ 296,000 | |||
100 mg | 在庫あり | ¥ 406,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 117,500 |
説明 | Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in the acute treatment of migraine studies. |
別名 | MK-1602 |
分子量 | 549.54 |
分子式 | C29H26F3N5O3 |
CAS No. | 1374248-77-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (445.83 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ubrogepant 1374248-77-7 GPCR/G Protein Neuroscience CGRP Receptor MK 1602 MK-1602 inhibit Inhibitor Calcitonin gene-related peptide receptor MK1602 inhibitor